Type 2 diabetes (T2DM) constitutes an enormous health burden in the United States, and despite increasing prevalence there are still major gaps in understanding the pathogenesis of this disease. The overall goal of this proposal is to determine the role of the regulatory peptide glucagon-like peptide 1 (GLP-1) to regulate glucose tolerance in nondiabetic persons and patients with T2DM. GLP-1 regulates islet hormone secretion and is essential for normal glucose tolerance. Importantly, GLP-1 is effective at lowering blood glucose in persons with T2DM, and two new classes of antidiabetes drugs are based on GLP-1 signaling. Despite the promise surrounding the clinical application of GLP-1 major questions remain about its mechanism of action. A better understanding of the endogenous GLP-1 system is critical for its optimal utilization to treat diabetes. It has generally been accepted that GLP-1 acts by an endocrine mechanism and that the intestine is the sole source of this peptide in the circulation. However, there is emerging evidence to question the importance of circulating peptide as the primary mediator of GLP-1 actions. Moreover, since the GLP-1 receptor is expressed in discrete regions of the brain and peripheral nervous system by neurons involved in metabolism, neural mediation of GLP-1 is a plausible alternative to an endocrine mechanism of action. We have data from recent experiments that implicate central and peripheral nervous signaling as contributing to GLP-1 mediated glucose tolerance. In this application we propose to determine the importance of neural mechanisms in mediation GLP-1 effects.
The specific aims of this project will determine: 1) the relative contributions of 2-cell and neural GLP-1 receptors to glucose tolerance;2) whether GLP-1 produced in the brain regulates insulin secretion and the control of glucose after meals;3) the role of circulating GLP-1 to mediate the gluco-regulatory effects of GLP-1 in healthy and diabetic humans. Investigating the role of neural GLP-1 signaling on insulin secretion and whole body glucose homeostasis will advance knowledge of metabolic regulation with the potential to expand the clinical role of the GLP-1 system for treating diabetes.

Public Health Relevance

GLP-1 is a GI hormone that has a broad range of effects to promote glucose disposal. Several new drugs have been developed that improve blood glucose control in diabetic patients by acting through the GLP-1 system. The goal of this project is to understand the different mechanisms by which GLP-1 acts to allow new and more refined applications of this system to the treatment of diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK057900-12
Application #
8508248
Study Section
Special Emphasis Panel (ZRG1-EMNR-H (02))
Program Officer
Laughlin, Maren R
Project Start
1999-09-30
Project End
2014-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
12
Fiscal Year
2013
Total Cost
$322,966
Indirect Cost
$117,255
Name
University of Cincinnati
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Inge, Thomas H; Prigeon, Ronald L; Elder, Deborah A et al. (2015) Insulin Sensitivity and β-Cell Function Improve after Gastric Bypass in Severely Obese Adolescents. J Pediatr 167:1042-8.e1
Salehi, Marzieh; Woods, Stephen C; D'Alessio, David A (2015) Gastric bypass alters both glucose-dependent and glucose-independent regulation of islet hormone secretion. Obesity (Silver Spring) 23:2046-52
Ottaway, Nickki; Mahbod, Parinaz; Rivero, Belen et al. (2015) Diet-induced obese mice retain endogenous leptin action. Cell Metab 21:877-82
Begg, Denovan P; May, Aaron A; Mul, Joram D et al. (2015) Insulin Detemir Is Transported From Blood to Cerebrospinal Fluid and Has Prolonged Central Anorectic Action Relative to NPH Insulin. Diabetes 64:2457-66
Elder, Deborah A; Hornung, Lindsey N; Herbers, Patricia M et al. (2015) Rapid deterioration of insulin secretion in obese adolescents preceding the onset of type 2 diabetes. J Pediatr 166:672-8
Ghosal, Sriparna; Nunley, Amanda; Mahbod, Parinaz et al. (2015) Mouse handling limits the impact of stress on metabolic endpoints. Physiol Behav 150:31-7
Ressler, Ilana B; Grayson, Bernadette E; Ulrich-Lai, Yvonne M et al. (2015) Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model. Am J Physiol Endocrinol Metab 308:E1076-84
Vahl, Torsten P; Aulinger, Benedikt A; Smith, Eric P et al. (2014) Meal feeding improves oral glucose tolerance in male rats and causes adaptations in postprandial islet hormone secretion that are independent of plasma incretins or glycemia. Am J Physiol Endocrinol Metab 307:E784-92
Salehi, Marzieh; Gastaldelli, Amalia; D'Alessio, David A (2014) Evidence from a single individual that increased plasma GLP-1 and GLP-1-stimulated insulin secretion after gastric bypass are independent of foregut exclusion. Diabetologia 57:1495-9
Grayson, B E; Fitzgerald, M F; Hakala-Finch, A P et al. (2014) Improvements in hippocampal-dependent memory and microglial infiltration with calorie restriction and gastric bypass surgery, but not with vertical sleeve gastrectomy. Int J Obes (Lond) 38:349-56

Showing the most recent 10 out of 51 publications